Cargando…
Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 2019
Despite steady progress over the past 3 decades in advancing drug and device therapies to reduce morbidity and mortality in heart failure with reduced ejection fraction, large registries of usual care demonstrate incomplete use of these evidence-based therapies in clinical practice. Potential strate...
Autores principales: | Leiva, Orly, Bhatt, Ankeet S., Vaduganathan, Muthiah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303658/ https://www.ncbi.nlm.nih.gov/pubmed/32888638 http://dx.doi.org/10.1016/j.hfc.2020.06.004 |
Ejemplares similares
-
Reply: Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients?
por: Bhatt, Ankeet S., et al.
Publicado: (2020) -
Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19
por: Bhatt, Ankeet S., et al.
Publicado: (2021) -
Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America
por: Bhatt, Ankeet S., et al.
Publicado: (2022) -
Impact of COVID-19 on Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory
por: Bhatt, Ankeet S., et al.
Publicado: (2023) -
Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches
por: Stienen, Susan, et al.
Publicado: (2020)